Osteoporosis Treatment in Young Adults

Introduction to Osteoporosis Management

• The American College of Physicians strongly recommends bisphosphonates as first-line therapy for osteoporosis based on high-quality evidence 3, 2
• Bisphosphonates have been extensively studied and have demonstrated efficacy in reducing fracture risk across multiple populations 4, 2
• Generic bisphosphonates are more cost-effective than denosumab for initial therapy 2

Treatment Algorithm for Osteoporosis

• Bisphosphonates are the recommended first-line pharmacologic treatment for osteoporosis due to their favorable balance of benefits, harms, patient preferences, and lower cost 1, 2
• Denosumab should be reserved as a second-line therapy for patients who have contraindications to bisphosphonates or who experience adverse effects from bisphosphonate therapy 1, 3

Patient Assessment and Treatment

• This patient has documented osteoporosis with a significant fracture risk, requiring initiation of treatment with an oral bisphosphonate as first-line therapy 4
• The patient's young age makes her different from the typical population studied in denosumab trials, making bisphosphonates the preferred initial option 2

Safety Considerations and Lifestyle Modifications

• Discontinuation of denosumab can lead to rebound bone turnover and increased risk of multiple vertebral fractures, requiring transition to a bisphosphonate after denosumab therapy 1
• Ensure adequate calcium and vitamin D supplementation, and recommend lifestyle modifications including weight-bearing exercise, smoking cessation, and limiting alcohol consumption 3, 2